Literature DB >> 23851291

Error-promoting DNA synthesis in ovarian cancer cells.

Heqiao Dai1, Robert J Hickey, Jianying Liu, Robert M Bigsby, Carita Lanner, Linda H Malkas.   

Abstract

OBJECTIVE: The objective of this study is to determine whether an altered DNA replication process is responsible for some of genetic damage observed in ovarian cancer.
METHODS: The replication fidelity of the DNA synthetic process was evaluated in both malignant and non-malignant human ovarian cells. The types of replication errors produced were identified. In addition, kinetic analyses of the efficiency of ovarian cancer DNA polymerases for misincorporating nucleotides were performed.
RESULTS: We report for the first time that ovarian cancer cells harbor an error promoting DNA replication apparatus which contributes to the decrease in DNA synthetic fidelity exhibited by these cells. Our study also shows that the decrease in DNA replication fidelity was not a result of an increased DNA replication activity. In addition, it was observed that the higher rate of DNA replication errors does not result in significant differences in the type of DNA replication-errors made during the DNA replication process; just the relative abundance. A detailed kinetic analysis of the efficiency of misincorporating nucleotides demonstrated that the DNA polymerases within the ovarian cancer cells exhibited a significant propensity for creating purine-pyrimidine nucleotide mismatches relative to non-malignant ovarian cells, while being only slightly more efficient at incorrectly pairing a purine nucleotide with a purine nucleotide.
CONCLUSIONS: All together, these data suggest that the systematic analysis of the DNA replication process in ovarian cancer could uncover information on some of the molecular mechanisms that drive the accumulation of genetic damage, and probably contribute to the pathogenesis of the disease.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA replication; Multiprotein complex; Ovarian cancer; Replication fidelity

Mesh:

Substances:

Year:  2013        PMID: 23851291      PMCID: PMC3796037          DOI: 10.1016/j.ygyno.2013.06.022

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  43 in total

1.  Thresholds of replication stress signaling in cancer development and treatment.

Authors:  Jiri Bartek; Martin Mistrik; Jirina Bartkova
Journal:  Nat Struct Mol Biol       Date:  2012-01-05       Impact factor: 15.369

Review 2.  More forks on the road to replication stress recovery.

Authors:  Chris Allen; Amanda K Ashley; Robert Hromas; Jac A Nickoloff
Journal:  J Mol Cell Biol       Date:  2011-02       Impact factor: 6.216

3.  Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.

Authors:  K R Geisinger; T E Kute; M J Pettenati; C E Welander; Y Dennard; L A Collins; M E Berens
Journal:  Cancer       Date:  1989-01-15       Impact factor: 6.860

4.  DNA replication error is frequent in ovarian granulosa cell tumors.

Authors:  M Suzuki; M Ohwada; Y Saga; K Ochiai; I Sato
Journal:  Cancer Genet Cytogenet       Date:  2000-10-01

5.  Chromosome abnormalities in human epithelial ovarian malignancies.

Authors:  H H Gallion; D E Powell; L W Smith; J K Morrow; A W Martin; J R van Nagell; E S Donaldson
Journal:  Gynecol Oncol       Date:  1990-09       Impact factor: 5.482

6.  DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary.

Authors:  J. Kaern; C.G. Tropé; G.B. Kristensen; V.M. Abeler; E.O. Pettersen
Journal:  Int J Gynecol Cancer       Date:  1993-11       Impact factor: 3.437

Review 7.  Human cancers express mutator phenotypes: origin, consequences and targeting.

Authors:  Lawrence A Loeb
Journal:  Nat Rev Cancer       Date:  2011-05-19       Impact factor: 60.716

8.  Human cell DNA replication is mediated by a discrete multiprotein complex.

Authors:  Hai Yan Jiang; Robert J Hickey; Waleed Abdel-Aziz; Timothy D Tom; Philip W Wills; Jianying Liu; Linda H Malkas
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

9.  Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients.

Authors:  Jin Song; Ie-ming Shih; Ritu Salani; Daniel W Chan; Zhen Zhang
Journal:  Clin Cancer Res       Date:  2007-11-02       Impact factor: 12.531

10.  Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.

Authors:  H Haapasalo; N B Atkin; Y Collan; E Pesonen; L Paljärvi
Journal:  Anal Cell Pathol       Date:  1991-09       Impact factor: 2.916

View more
  2 in total

1.  Identification of Key Genes and Pathway for Ovarian Neoplasms Using the OVDM1 Cell Line Based on Bioinformatics Analysis.

Authors:  Songna Yin; Juan Du; Jie Zhang; Xiang Zhang; Ke Ma
Journal:  Med Sci Monit       Date:  2019-06-09

2.  Mechanisms of base substitution mutagenesis in cancer genomes.

Authors:  Albino Bacolla; David N Cooper; Karen M Vasquez
Journal:  Genes (Basel)       Date:  2014-03-05       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.